Lawrence M. Alleva, Director at Galera Therapeutics, Inc. (GRTX), bought 2,325 shares at $10.22 ($24K) on 2020-11-13, disclosed to the SEC on 2020-11-17.
Open-market purchase of $24k GRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| GRTX | BUY | 2021-06-03 | $35K | — | Filing → |
| MRSN | BUY | 2021-06-03 | $15K | — | Filing → |
| ADAP | BUY | 2020-06-11 | $24K | — | Filing → |